EP2982696
Meðhöndlun á báðu eitilfrumuhvítblæði
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
6.11.2009EP published:
27.3.2019EP application number:
15185767.9
EP translation filed:
15.5.2019Grant published:
15.6.2019EPO information:
European Patent Register
Max expiry date:
5.11.2029Expiry date:
5.11.2026Next due date:
30.11.2026
Title:
TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
Timeline
Today
6.11.2009EP application
27.3.2019EP Publication
15.5.2019Translation submitted
15.6.2019Registration published
5.11.2026Expires
Owner
Name:
Amgen Research (Munich) GmbHAddress:
Staffelseestrasse 2, 81477, München, DE
Inventor
Name:
ZUGMAIER, GerhardAddress:
Munich, DE
Name:
DEGENHARD, EvelynAddress:
Munich, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
112323 PDate:
7.11.2008Country:
US
Number:
183291 PDate:
2.6.2009Country:
US
Classification
Categories:
C07K 16/28, C07K 16/46, A61P 35/02
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 8.10.2019
Expires: 5.11.2020
Payer: Árnason Faktor
Number: 12
Paid: 6.10.2020
Expires: 5.11.2021
Payer: Árnason Faktor ehf.
Number: 13
Paid: 7.10.2021
Expires: 5.11.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 20.10.2022
Expires: 5.11.2023
Payer: Patice ehf.
Number: 15
Paid: 26.10.2023
Expires: 5.11.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 23.10.2024
Expires: 5.11.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 7.11.2025
Expires: 5.11.2026
Payer: Árnason Faktor ehf.